Skip to main content
Premium Trial:

Request an Annual Quote

Benchware, mpiBlast, EBIMed, GenePart, Flu Sequence Dataset Explorer, Splign, gMap, STN AnaVist, Neil Dey, Rudolph Potenzone, Steven Enoch

Premium

Downloads & Upgrades

Tripos said that it will launch its Benchware laboratory informatics suite at the Drug Discovery Technology conference in Boston, Aug. 9-11. The Benchware portfolio includes: Benchware 3D Explorer, a chemical visualization and decision-support tool; Benchware HTS DataMiner, a lead series prioritization tool that was formerly marketed by Tripos under the product name SARNavigator; Benchware LibraryMaker for enumerating parallel compound libraries; and Benchware LibraryDesigner for helping chemists decide which reactants to use when making parallel compound libraries.


Version 1.4.0 of mpiBlast is available at http://mpiblast.org/pmwiki/pmwiki.php?n=Downloads.Stable. The release includes a number of enhancements in performance, scalability, and stability, according to its development team, and attained a 305-fold speedup over NCBI Blast with 128 CPUs. The previous mpiBlast release provided only 180-fold speedup on the same data set.


EBIMed, a document retrieval and extraction tool, is available from the European Bioinformatics Institute at http://www.ebi.ac.uk/Rebholz-srv/ebimed. The extracted information provides an overview on associations between UniProt proteins, GO annotations, drug names, and species, as well as links to the relevant sentences, the original abstracts, and the biological databases that contain them.


Informed Bioscience of Bozeman, Mont., has released a beta version of its GenePart microarray-analysis software. The company claims that the software is able to "almost perfectly" discriminate tissue classes based on microarray data.


The National Center for Biotechnology Information has released the Flu Sequence Dataset Explorer, an interactive tool for performing preliminary analysis on protein and nucleotide sequences from the NCBI Influenza Sequence Database, at http://www.ncbi.nlm.nih.gov/genomes/DatasetExplorer/FLU/fluPage.cgi. NCBI has also released Splign (Spliced Alignment), a new utility for computing cDNA-to-genomic alignments or spliced sequence alignments, using Blast, at http://www.ncbi.nlm.nih.gov/sutils/splign/splign.cgi. Additionally, the institute released gMap, a microbial genome comparison tool, at http://www.ncbi.nlm.nih.gov/sutils/gmap.cgi.


Chemical Abstracts Service and FIZ Karlsruhe have launched STN AnaVist, a patent-analysis software tool. Features include content from multiple sources, including CAplus, PCT, and the US full-text patent databases; relationships between structured and unstructured data; data grouping and cleanup; concept standardization; and flexible creation of result sets. The software is available through Dec. 31 at no charge at http://www.cas.org/stnanavist/index.html.

 

People in the News

Definiens has appointed Neil Dey as vice president of business development and marketing. The company said in a statement that Dey's appointment is "the first of multiple planned moves to prepare the company for significant growth in the Americas and Europe throughout 2005 and 2006." Dey joins the firm from BioImagene, where he served as vice president of business development. He was also head of business development at Impath, and has held senior executive positions at Genmethrax, Thomas Jefferson Medical University, and Ciba-Geigy (Novartis).


Rudolph Potenzone has joined CambridgeSoft as vice president of enterprise solutions. Potenzone most recently served at Ingenuity, which he joined last March as senior vice president of business development and strategic planning. Potenzone was previously CEO of Lion Bioscience's US subsidiary, Lion Bioscience Inc. He also worked at MDL as senior vice president for marketing and development, and held positions at Chemical Abstracts Service and Polygen/Molecular Simulations.


Peakdale Molecular has appointed Steven Enoch to head its computational chemistry department. Enoch joins the firm from Cyprotex Discovery, where he served as a chemoinformatician.

Filed under

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.